Xu Wen-Tao, An Xiao-Bin, Chen Mei-Jie, Ma Jing, Wang Xu-Qiao, Yang Ji-Nan, Wang Qin, Wang Dong-Yang, Wu Yan, Zeng Lu, Qu Yang, Zhao Bowen, Ai Jing
Department of Pharmacology, The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, College of Pharmacy of Harbin Medical University, Heilongjiang Province, Harbin, 150086, China.
College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, China.
Mol Neurobiol. 2025 Jun;62(6):6869-6883. doi: 10.1007/s12035-024-04471-3. Epub 2024 Sep 14.
"Brain fog," a persistent cognitive impairment syndrome, stands out as a significant neurological aftermath of coronavirus disease 2019 (COVID-19). Yet, the underlying mechanisms by which COVID-19 induces cognitive deficits remain elusive. In our study, we observed an upregulation in the expression of genes linked to the inflammatory response and oxidative stress, whereas genes associated with cognitive function were downregulated in the brains of patients infected with COVID-19. Through single-nucleus RNA sequencing (snRNA-seq) analysis, we found that COVID-19 infection triggers the immune responses in microglia and astrocytes and exacerbates oxidative stress in oligodendrocytes, oligodendrocyte progenitors (OPCs), and neurons. Further investigations revealed that COVID-19 infection elevates LUC7L2 expression, which inhibits mitochondrial oxidative phosphorylation (OXPHOS) and suppresses the expression of mitochondrial complex genes such as MT-ND1, MT-ND2, MT-ND3, MT-ND4L, MT-CYB, MT-CO3, and MT-ATP6. A holistic approach to protect mitochondrial complex function, rather than targeting a single molecular, should be an effective therapeutic strategy to prevent and treat the long-term consequences of "long COVID."
“脑雾”是一种持续存在的认知障碍综合征,是2019冠状病毒病(COVID-19)严重的神经后遗症。然而,COVID-19导致认知缺陷的潜在机制仍不清楚。在我们的研究中,我们观察到与炎症反应和氧化应激相关的基因表达上调,而与认知功能相关的基因在COVID-19感染患者的大脑中被下调。通过单核RNA测序(snRNA-seq)分析,我们发现COVID-19感染触发了小胶质细胞和星形胶质细胞的免疫反应,并加剧了少突胶质细胞、少突胶质前体细胞(OPC)和神经元中的氧化应激。进一步研究表明,COVID-19感染会提高LUC7L2的表达,从而抑制线粒体氧化磷酸化(OXPHOS),并抑制线粒体复合基因如MT-ND1、MT-ND2、MT-ND3、MT-ND4L、MT-CYB、MT-CO3和MT-ATP6的表达。保护线粒体复合功能的整体方法,而不是针对单个分子,应该是预防和治疗“长新冠”长期后果的有效治疗策略。